220 related articles for article (PubMed ID: 30836219)
21. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
22. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
23. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
de Angelis M; Morra S; Scheipner L; Siech C; Jannello LMI; Baudo A; Goyal JA; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2024 Mar; 42(1):193. PubMed ID: 38530480
[TBL] [Abstract][Full Text] [Related]
24. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
[TBL] [Abstract][Full Text] [Related]
25. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
[TBL] [Abstract][Full Text] [Related]
26. Impact of warm ischaemia time on postoperative renal function after partial nephrectomy for clinical T1 renal cell carcinoma: a propensity score-matched study.
Lee H; Song BD; Byun SS; Lee SE; Hong SK
BJU Int; 2018 Jan; 121(1):46-52. PubMed ID: 28749082
[TBL] [Abstract][Full Text] [Related]
27. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
[No Abstract] [Full Text] [Related]
28. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
Mason RJ; Atwell TD; Lohse C; Bhindi B; Weisbrod A; Boorjian SA; Leibovich BC; Schmit GD; Thompson RH
BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
[TBL] [Abstract][Full Text] [Related]
29. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
[TBL] [Abstract][Full Text] [Related]
31. Treatment Trends and Long-Term Survival Associated with Cryotherapy and Partial Nephrectomy for Small Renal Masses in the National Cancer Database Using Propensity Score Matching.
Kitley W; Sulek J; Sundaram C; Bahler CD
J Endourol; 2019 May; 33(5):408-414. PubMed ID: 30808185
[No Abstract] [Full Text] [Related]
32. Impact of positive surgical margins on overall survival after partial nephrectomy-A matched comparison based on the National Cancer Database.
Shum CF; Bahler CD; Sundaram CP
Urol Oncol; 2018 Mar; 36(3):90.e15-90.e21. PubMed ID: 29223360
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
[TBL] [Abstract][Full Text] [Related]
34. Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes.
Simone G; Tuderti G; Ferriero M; Papalia R; Misuraca L; Minisola F; Costantini M; Mastroianni R; Sentinelli S; Guaglianone S; Gallucci M
Eur J Surg Oncol; 2016 Nov; 42(11):1744-1750. PubMed ID: 27593224
[TBL] [Abstract][Full Text] [Related]
35. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
36. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
37. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project).
Mir MC; Pavan N; Capitanio U; Antonelli A; Derweesh I; Rodriguez-Faba O; Linares E; Takagi T; Rha KH; Fiori C; Maurer T; Zang C; Mottrie A; Umari P; Long JA; Fiard G; De Nunzio C; Tubaro A; Tracey AT; Ferro M; De Cobelli O; Micali S; Bevilacqua L; Torres J; Schips L; Castellucci R; Dobbs R; Quarto G; Bove P; Celia A; De Concilio B; Trombetta C; Silvestri T; Larcher A; Montorsi F; Palumbo C; Furlan M; Bindayi A; Hamilton Z; Breda A; Palou J; Aguilera A; Tanabe K; Raheem A; Amiel T; Yang B; Lima E; Crivellaro S; Perdona S; Gregorio C; Barbati G; Porpiglia F; Autorino R
World J Urol; 2020 Jan; 38(1):151-158. PubMed ID: 30937569
[TBL] [Abstract][Full Text] [Related]
38. SEER study of ablation versus partial nephrectomy in cT1A renal cell carcinoma.
Zhou M; Mills A; Noda C; Ramaswamy R; Akinwande O
Future Oncol; 2018 Jul; 14(17):1711-1719. PubMed ID: 29939095
[TBL] [Abstract][Full Text] [Related]
39. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
[TBL] [Abstract][Full Text] [Related]
40. An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis.
Bianchi M; Becker A; Trinh QD; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Graefen M; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):1184-90. PubMed ID: 23651446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
